Epidermal melanocytes in segmental vitiligo show altered expression of E‐cadherin, but not P‐cadherin
2018; Oxford University Press; Volume: 178; Issue: 5 Linguagem: Francês
10.1111/bjd.16352
ISSN1365-2133
AutoresC Grill, Laïla Benzekri, Alain Rubod, Zackie Aktary, Khaled Ezzedine, Alain Taı̈eb, Yvon Gauthier, Lionel Larue, Véronique Delmas,
Tópico(s)melanin and skin pigmentation
ResumoBritish Journal of DermatologyVolume 178, Issue 5 p. 1204-1206 Research Letter Epidermal melanocytes in segmental vitiligo show altered expression of E-cadherin, but not P-cadherin C. Grill, C. Grill Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, FranceSearch for more papers by this authorL. Benzekri, L. Benzekri Mohammed V University in Rabat, Department of Dermatology, Ibn Sina University Hospital, Rabat, MoroccoSearch for more papers by this authorA. Rubod, A. Rubod Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, FranceSearch for more papers by this authorZ. Aktary, Z. Aktary Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, FranceSearch for more papers by this authorK. Ezzedine, K. Ezzedine orcid.org/0000-0002-5468-4589 Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France INSERM U1035, University of Bordeaux, Bordeaux, FranceSearch for more papers by this authorA. Taïeb, A. Taïeb Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France INSERM U1035, University of Bordeaux, Bordeaux, FranceSearch for more papers by this authorY. Gauthier, Y. Gauthier Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France INSERM U1035, University of Bordeaux, Bordeaux, FranceSearch for more papers by this authorL. Larue, Corresponding Author L. Larue lionel.larue@curie.fr orcid.org/0000-0002-2010-6107 Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, France Correspondence: Lionel Larue. E-mail: lionel.larue@curie.frSearch for more papers by this authorV. Delmas, V. Delmas Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, FranceSearch for more papers by this author C. Grill, C. Grill Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, FranceSearch for more papers by this authorL. Benzekri, L. Benzekri Mohammed V University in Rabat, Department of Dermatology, Ibn Sina University Hospital, Rabat, MoroccoSearch for more papers by this authorA. Rubod, A. Rubod Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, FranceSearch for more papers by this authorZ. Aktary, Z. Aktary Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, FranceSearch for more papers by this authorK. Ezzedine, K. Ezzedine orcid.org/0000-0002-5468-4589 Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France INSERM U1035, University of Bordeaux, Bordeaux, FranceSearch for more papers by this authorA. Taïeb, A. Taïeb Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France INSERM U1035, University of Bordeaux, Bordeaux, FranceSearch for more papers by this authorY. Gauthier, Y. Gauthier Department of Dermatology and Pediatric Dermatology, National Reference Centre for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France INSERM U1035, University of Bordeaux, Bordeaux, FranceSearch for more papers by this authorL. Larue, Corresponding Author L. Larue lionel.larue@curie.fr orcid.org/0000-0002-2010-6107 Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, France Correspondence: Lionel Larue. E-mail: lionel.larue@curie.frSearch for more papers by this authorV. Delmas, V. Delmas Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France University Paris-Sud, University Paris-Saclay, CNRS, UMR 3347, Orsay, France Equipe Labellisée Ligue Contre le Cancer, Orsay, FranceSearch for more papers by this author First published: 16 January 2018 https://doi.org/10.1111/bjd.16352Citations: 6 Funding sources: This work was supported by the Ligue Contre le Cancer – Comité de l'Oise, INCa, ITMO Cancer, ARC, and is covered by the programme 'Investissements d'Avenir', launched by the French Government and implemented by ANR Labex CelTisPhyBio (ANR-11-LBX-0038 and ANR-10-IDEX-0001-02 PSL). C.G. has a fellowship from the Fondation ARC. Conflicts of interest: none to declare. L.L. and V.D. are joint last authors. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume178, Issue5May 2018Pages 1204-1206 RelatedInformation
Referência(s)